Effect of Propofol or Etomidate as General Anaesthesia Induction on Gastric Cancer: A Retrospective Cohort Study with 10 Years’ Follow-Up

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics. Cancer Commun. 2019;39:22. doi:10.1186/s40880-019-0368-6
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Fujiogi M, Matsui H, et al. Short-term outcomes of laparoscopic and open total gastrectomy for gastric cancer: a nationwide retrospective cohort analysis. Ann Surg Oncol. 2020;27:518–526. doi:10.1245/s10434-019-07688-y
   PubMed Web of Science ®Google Scholar
• Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21:67. doi:10.1007/s11912-019-0820-4
   PubMed Web of Science ®Google Scholar
• Jeon BH, Choi M, Lee J, et al. Relationships between gastrointestinal symptoms, uncertainty, and perceived recovery in patients with gastric cancer after gastrectomy. Nurs Health Sci. 2016;18:23–29. doi:10.1111/nhs.12219
   PubMed Web of Science ®Google Scholar
• Longhini F, Bruni A, Garofalo E, et al. Anesthetic strategies in oncological surgery: not only a simple sleep, but also impact on immunosuppression and cancer recurrence. Cancer Manag Res. 2020;12:931–940. doi:10.2147/CMAR.S237224
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–99. doi:10.3322/caac.21388
   PubMed Web of Science ®Google Scholar
• Gong YB, Zhu Z, Wang X, et al. [Influence of different biological behaviors on prognosis of patients with advanced gastric cancer at the same TNM stage]. Zhong Hua Wei Chang Wai Ke Za Zhi. 2020;23:953–962. Chinese.
   PubMedGoogle Scholar
• Sahinovic MM, Struys MM, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57:1539–1558. doi:10.1007/s40262-018-0672-3
   PubMed Web of Science ®Google Scholar
• Fengler BT. Should etomidate be used for rapid-sequence intubation induction in critically ill septic patients? Am J Emerg Med. 2008;26:229–232. doi:10.1016/j.ajem.2007.03.032
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumor Biol. 2017;39:1010428317714626. doi:10.1177/1010428317714626
   Google Scholar
• Forman SA, Warner DS. Clinical and molecular pharmacology of etomidate. Anesthesiology. 2011;114:695–707. doi:10.1097/ALN.0b013e3181ff72b5
   PubMed Web of Science ®Google Scholar
• Zhou M, Liu W, Peng J, et al. Impact of propofol epidural anesthesia on immune function and inflammatory factors in patients undergoing gastric cancer surgery. Am J Transl Res. 2021;13:3064–3073.
   PubMed Web of Science ®Google Scholar
• Miyauchi W, Shishido Y, Kono Y, et al. Less invasive surgery for remnant stomach cancer after esophago-proximal gastrectomy with ICG-guided blood flow evaluation: a case report. Yonago Acta Med. 2018;61:187–191. doi:10.33160/yam.2018.09.007
   PubMed Web of Science ®Google Scholar
• Cao Y, Fan L, Li L, et al. Propofol suppresses cell proliferation in gastric cancer cells through NRF2-mediated polyol pathway. Clin Exp Pharmacol Physiol. 2021. doi:10.1111/1440-1681.13595
   Web of Science ®Google Scholar
• Lin L, Jiang H, Huang M, et al. Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway. Oncol Rep. 2015;34:663–672. doi:10.3892/or.2015.4010
   PubMed Web of Science ®Google Scholar
• Yu X, Gao Y, Zhang F. Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR-328 and down-regulating ADAM8. Basic Clin Pharmacol Toxicol. 2019;125:271–278. doi:10.1111/bcpt.13224
   PubMed Web of Science ®Google Scholar
• Song J, Shen Y, Zhang J, et al. Mini profile of potential anticancer properties of propofol. PLoS One. 2014;9:e114440. doi:10.1371/journal.pone.0114440
   PubMed Web of Science ®Google Scholar
• Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29:477–486. doi:10.1080/08923970701675085
   PubMed Web of Science ®Google Scholar
• González-Correa JA, Cruz-Andreotti E, Arrebola MM, et al. Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients. Naunyn Schmiedebergs Arch Pharmacol. 2008;376:331–339. doi:10.1007/s00210-007-0220-4
   PubMed Web of Science ®Google Scholar
• Lai HC, Lee MS, Lin C, et al. Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. Br J Anaesthesia. 2019;123:151–160. doi:10.1016/j.bja.2019.04.057
   PubMed Web of Science ®Google Scholar
• Wu ZF, Lee MS, Wong CS, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery. Anesthesiology. 2018;129:932–941. doi:10.1097/ALN.0000000000002357
   PubMed Web of Science ®Google Scholar
• Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology. 2016;124:69–79. doi:10.1097/ALN.0000000000000936
   PubMed Web of Science ®Google Scholar
• Jun IJ, Jo JY, Kim JI, et al. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: a retrospective observational study. Sci Rep. 2017;7:14020. doi:10.1038/s41598-017-14147-9
   PubMed Web of Science ®Google Scholar
• Oh TK, Kim K, Jheon S, et al. Long-term oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery: a retrospective propensity matching analysis. Cancer Control. 2018;25:1073274818775360. doi:10.1177/1073274818775360
   Web of Science ®Google Scholar
• Enlund M, Berglund A, Andreasson K, et al. The choice of anaesthetic–sevoflurane or propofol–and outcome from cancer surgery: a retrospective analysis. Ups J Med Sci. 2014;119:251–261. doi:10.3109/03009734.2014.922649
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Yamamoto K, Ohmoto N, et al. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med. 2000;28:1101–1106. doi:10.1097/00003246-200004000-00032
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med. 2002;30:904–907. doi:10.1097/00003246-200204000-00032
   PubMed Web of Science ®Google Scholar
• Haga Y, Beppu T, Doi K, et al. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med. 1997;25:1994–2000. doi:10.1097/00003246-199712000-00016
   PubMed Web of Science ®Google Scholar
• Becher RD, Hoth JJ, Miller PR, et al. Systemic inflammation worsens outcomes in emergency surgical patients. J Trauma Acute Care Surg. 2012;72:1140–1149. doi:10.1097/TA.0b013e3182516a97
   PubMed Web of Science ®Google Scholar
• Dieleman JM, Nierich AP, Rosseel PM, et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761–1767. doi:10.1001/jama.2012.14144
   PubMed Web of Science ®Google Scholar
• Laaninen M, Sand J, Nordback I, et al. Perioperative hydrocortisone reduces major complications after pancreaticoduodenectomy: a randomized controlled trial. Ann Surg. 2016;264:696–702. doi:10.1097/SLA.0000000000001883
   PubMed Web of Science ®Google Scholar
• Schaefer MS, Raub D, Xu X, et al. Association between propofol dose and 1-year mortality in patients with or without a diagnosis of solid cancer. Br J Anaesth. 2020;124:271–280. doi:10.1016/j.bja.2019.11.028
   PubMed Web of Science ®Google Scholar
• Wolfer AM, Scott AJ, Rueb C, et al. Longitudinal analysis of serum oxylipin profile as a novel descriptor of the inflammatory response to surgery. J Transl Med. 2017;15:83. doi:10.1186/s12967-017-1171-2
   PubMed Web of Science ®Google Scholar
• Jia J, Sun Y, Hu Z, et al. Propofol inhibits the release of interleukin-6, 8 and tumor necrosis factor-α correlating with high-mobility group box 1 expression in lipopolysaccharides-stimulated RAW 264.7 cells. BMC Anesthesiol. 2017;17:148. doi:10.1186/s12871-017-0441-0
   PubMed Web of Science ®Google Scholar